Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsoriVascular S.L.U.

About this trial

Prospective, Single-arm, Multi-centre Study to Evaluate the Efficacy and Safety of the iNstroke 4F Thromboaspiration Catheter in Patients with Acute Ischaemic Stroke due to Primary Distal Medium Vessel Occlusions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subjects aged ≥ 18 years.

Subjects with symptom onset up to 24 hours.

Isolated primary demonstrated occlusion in a distal medium vessel (Non-dominant or distal M2-MCA segment, M3 or M4 segments of MCA, A2-A3 segments of ACA, P1, P2 and P3 segments of PCA) identified by magnetic resonance angiography (MRA) or computed tomography angiography (CTA).

Baseline NIHSS score ≥5 assessed before the procedure.

Disqualifiers

Subjects aged < 18.

Suspected secondary DMVO. Suspicion or evidence of primary LVO whether it has been treated or not with fibrinolytic therapy or mechanical thrombectomy that subsequently develops a DMVO.

Baseline NIHSS score <5 assessed before the procedure.

Pre-stroke mRS score >2.

Trial design

Design model

Single group

Treatments tested in this trial

  • Thromboaspiration catheter

    Device

    Patients to undergo thromboaspiration with iNstroke 4F

Treatment groups

57 Participants
are divided into 1 treatment group
Group A: Thromboaspiration using iNstroke 4F aspiration catheterOther 1 intervention

Trial outcomes

Primary outcomes

1

Recanalization Endpoint

Recanalization rate with a modified thrombolysis in cerebral infarction scale (mTICI) score ≥2b in ≤3 revascularization passes using iNstroke 4F aspiration catheter, alone or in conjunction with a SR.

Time frame
Intra-procedure

Secondary outcomes

1

Recanalization Endpoint

Proportion of subjects treated with iNstroke 4F alone with complete recanalization in primary DMVO defined as an mTICI ≥2b, after iNstroke 4F aspiration catheter alone (ADAPT) was used as a first-line therapy

Time frame
Intra-procedure
2

Recanalization Endpoint

Proportion of subjects treated with iNstroke 4F in conjunction with a stent retriever having complete recanalization in primary DMVO defined as achieving an mTICI ≥2b, after iNstroke 4F aspiration catheter, in conjunction with a stent retriever (SR), was used as a first-line therapy.

Time frame
Intra-procedure
3

Recanalization Endpoint

Proportion of subjects with mTICI≥2b, mTICI≥2c and mTICI 3 after first pass with iNstroke 4F aspiration catheter used both alone and in conjunction with a SR.

Time frame
Intra-procedure
4

Recanalization Endpoint

Time from groin puncture to achievement of complete recanalization (mTICI ≥2b), or if not achieved, until the final angiogram time, in patients treated with iNstroke 4F aspiration catheter, alone or in conjunction with a SR, as a first-line therapy.

Time frame
Intra-procedure

Other outcomes

1

Exploratory Recanalization Endpoint

Proportion of subjects in which a switch of technique (from ADAPT to combined or from combined to ADAPT) with iNstroke 4F aspiration catheter was used to successfully perform the thrombectomy.

Time frame
Intra-procedure
2

Exploratory Recanalization Endpoint

Proportion of subjects in which an aspiration catheter device with a 4F caliber different from iNstroke 4F aspiration catheter was used as a rescue therapy.

Time frame
Intra-procedure
3

Exploratory Recanalization Endpoint

Proportion of cases in which iNstroke 4F aspiration catheter (alone or in conjunction with a SR) successfully reached the site of occlusion.

Time frame
Intra-procedure
4

Exploratory Recanalization Endpoint

Number of passes with iNstroke 4F aspiration catheter until recanalization.

Time frame
Intra-procedure

Sponsors and contacts

Click on the lead sponsor to view all of their trials.